Press "Enter" to skip to content

Statement from FDA Commissioner Scott Gottlieb, M.D., on the agency’s efforts to improve drug quality through vigilant oversight of data integrity and good manufacturing practice

FDA releases guidance with recommendations for drug manufacturers regarding good manufacturing practices and data integrity

Original source: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm628244.htm

Also Read:   Baby powder manufacturer voluntarily recalls products for asbestos